Latham & Watkins advised Owlet in the offering, and DLA Piper advised Titan Partners Group, as underwriter. Owlet, Inc. (NYSE:OWLT), the pioneer of smart infant monitoring,...
You must be a Standard 1 Year member to access this content.
DLA Piper advised Cantor Fitzgerald on the transaction. The transaction consisted in an offer to exchange certain outstanding warrants to purchase Class A ordinary shares of...
You must be a Standard 1 Year member to access this content.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Elicio, while DLA Piper advised JonesTrading Institutional Services (Jones), as agent and as sole book-running manager in the...
You must be a Standard 1 Year member to access this content.
DLA Piper advised Custom Health Inc., while Greenberg Traurig advised Berenson Acquisition Corp. on the deal. Custom Health Inc, a digital healthcare firm, announced its business...
You must be a Standard 1 Year member to access this content.
DLA Piper advised Axsome Therapeutics on the offering. Axsome Therapeutics, Inc. (Axsome), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous...
You must be a Standard 1 Year member to access this content.
DLA Piper advised Iovance Biotherapeutics in the deal. Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) announced its definitive agreement with Clinigen Limited to acquire Proleukin® (aldesleukin), an interleukin-2...
You must be a Standard 1 Year member to access this content.
DLA Piper represented Axsome Therapeutics in the transaction. Axsome Therapeutics, a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, announced...
You must be a Standard 1 Year member to access this content.
